Security Asset Management Ligand Pharmaceuticals Inc Transaction History
Security Asset Management
- $170 Million
- Q1 2023
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
238Shares Held
16.5MCall Options Held
77.9KPut Options Held
25K-
Black Rock Inc. New York, NY2.87MShares$286 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$188 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.03MShares$103 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$101 Million0.04% of portfolio
-
Stephens Investment Management Group LLC697KShares$69.5 Million0.7% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.68B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...